PETER KEKLAK: Open Payments
NPI 1760588669 · EGG HARBOR TWP, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$385 in 25 payments from 7 companies in 2025. Trend: 2023 $700 · 2024 $733 · 2025 $385
Food & beverage: $385
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $204 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $55 |
| GENZYME CORPORATION | 2 | $40 |
| PFIZER INC. | 2 | $31 |
| Madrigal Pharmaceuticals | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| Gilead Sciences, Inc. | 1 | $16 |
Products named: RINVOQ, XIFAXAN, DUPIXENT, SKYRIZI, CREON, REZDIFFRA, ZENPEP, XELJANZ.
Industry payments across NJ — which companies pay providers there.
